COVID-19 – Govt Announces Vaccine Type to be Used
The government has decided on the type of vaccine it plans to use for the eventual vaccination program in Indonesia.
This handout photo taken and released on August 11, 2020 by Presidential palace shows President Joko Widodo (C) visiting the Bio Farma Pharmacy that produce vaccines for COVID-19 coronavirus in Bandung, West Java. - Indonesia on August 11, 2020 launched human trials of a Chinese-made coronavirus vaccine with some 1,600 volunteers slated to take part in the six-month study.
JAKARTA, KOMPAS— The government has decided on the type of vaccine it plans to use for the eventual vaccination program in Indonesia. The vaccines used will be produced by state-owned pharmaceutical company PT Bio Pharma, Britain’s AstraZeneca, the United States’ Moderna and Pfizer-BioNTech, as well as China’s Sinovac Biotech.
This decision is stipulated in Health Ministry Decree No. 9860/2020 on the arrangement of vaccines used in the COVID-19 vaccination program. Health Ministry spokesperson Wisdyawati confirmed the regulation on Friday.